A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

This study tests a new drug called GNC-077 in people with advanced non-small cell lung cancer (NSCLC) or other solid tumors. It is an early-phase trial that first checks how safe the drug is and then looks at whether it helps shrink tumors. **You may be eligible if...** - You are between 18 and 75 years old (or 18 and older in Stage Ib) - You have locally advanced or metastatic non-small cell lung cancer, or another solid tumor - Your cancer has progressed after standard treatments - You are in good physical health (ECOG 0–1) **You may NOT be eligible if...** - You have active brain metastases that are untreated or unstable - You have an active autoimmune disease or are on immune-suppressing medications - You have serious heart, liver, or kidney problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.